News
First intranasal anaphylaxis drug launches in Germany
An alternative to epinephrine autoinjectors that can be delivered by …
21098 items found
News
Vor Bio revives, thanks to $4bn+ licensing deal with RemeGen
US biotech Vor Bio has turned to China's RemeGen to revitalise its …
News
Nektar eyes pivotal trials for eczema drug cast off by Lilly
Nektar Therapeutics has said phase 2b results show it was right to …
R&D
The diagnostic odyssey: Challenges and opportunities in transthyretin amyloidosis (ATTR)
This publication has not been sponsored or paid for by any external …
News
Could a vaccine adjuvant be protective against dementia?
Scientists behind a study suggesting GSK's respiratory syncytial …
News
Biogen races into phase 3 with Spinraza follow-up
Biogen is looking to the future of its spinal muscular atrophy (SMA) …
Sales & Marketing
Sponsored
12 Questions with Chris Venezia
As the CEO of ProofPilot, Chris Venezia has a track record of success …
Oncology
On oncological hope at ASCO 2025: In conversation with City of Hope Orange County's Dr Pashtoon Kasi
Liquid biopsies are reshaping colon cancer detection, particularly in …
News
Kymera signs $750m cancer deal with Gilead as Sanofi opts in
Kymera Therapeutics is celebrating the signing of two partnerships, …
R&D
Partner Content
7th TRP Europe | November 2025, Amsterdam | Agenda Released
Radioligand therapy is evolving rapidly . With new targets like HER2 …
News
FDA probing deaths with DMD gene therapy Elevidys
The FDA has launched a formal investigation into two reports of fatal …
News
Alarm as study finds global vaccination coverage stalls
Millions of children around the world are at risk of serious …
R&D
Built for one: The case for custom formulation in the era of...
The precision medicine market is projected to exceed $175 billion by 2030, reflecting continued growth and interest in innovative approaches that tailor therapeutics that accounts for diffe
Market Access
Sponsored
Bridging research and clinical guidelines – interactive stra...
Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
R&D
Deep Dive: Research and Development 2025
Every breakthrough in medicine, every new treatment that changes lives, starts with research.
R&D
Life Sciences Industry Report - Biologics and Generics
The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.
Oncology
Life Sciences Industry Report - Oncology
Developments in the oncology space in 2024 brought hope to both industry and patients.
R&D
Partner Content
16th World ADC San Diego 2025
The World’s Largest, Longest-Standing & Most Comprehensive Antibody-Drug Conjugate Conference
Digital
Partner Content
Axtria Ignite 2025: Leading in an Agentic Era
Axtria’s flagship event is almost here! Axtria Ignite 2025 is taking place 4th to 5th June at the Princeton Marriott at Forrestal in New Jersey. This